SouthState Corp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
7,021
-1
-0% -$150 0.05% 202
2026
Q1
$1.07M Hold
7,022
0.05% 197
2025
Q4
$968K Sell
7,022
-219
-3% -$28.7K 0.04% 207
2025
Q3
$929K Sell
7,241
-1,051
-13% -$128K 0.04% 203
2025
Q2
$1M Sell
8,292
-726
-8% -$81.8K 0.04% 202
2025
Q1
$1.01M Sell
9,018
-948
-10% -$101K 0.05% 197
2024
Q4
$970K Sell
9,966
-429
-4% -$45.7K 0.06% 150
2024
Q3
$1.2M Sell
10,395
-401
-4% -$45.5K 0.08% 134
2024
Q2
$1.15M Sell
10,796
-189
-2% -$19K 0.08% 132
2024
Q1
$1.06M Sell
10,985
-324
-3% -$33.2K 0.08% 135
2023
Q4
$1.14M Sell
11,309
-100
-0.9% -$9.65K 0.1% 126
2023
Q3
$1.16M Sell
11,409
-900
-7% -$91.4K 0.11% 123
2023
Q2
$1.24M Sell
12,309
-1,984
-14% -$198K 0.11% 125
2023
Q1
$1.31M Sell
14,293
-447
-3% -$39K 0.12% 126
2022
Q4
$1.34M Sell
14,740
-747
-5% -$62.9K 0.12% 129
2022
Q3
$1.18M Sell
15,487
-920
-6% -$76.3K 0.12% 128
2022
Q2
$1.39M Sell
16,407
-223
-1% -$19.6K 0.13% 124
2022
Q1
$1.46M Sell
16,630
-1,755
-10% -$152K 0.12% 132
2021
Q4
$1.61M Sell
18,385
-1,173
-6% -$97.4K 0.13% 126
2021
Q3
$1.6M Sell
19,558
-1,029
-5% -$92.6K 0.13% 119
2021
Q2
$1.88M Sell
20,587
-3,140
-13% -$280K 0.16% 111
2021
Q1
$2.03M Sell
23,727
-5,640
-19% -$506K 0.19% 103
2020
Q4
$2.77M Sell
29,367
-14,531
-33% -$1.27M 0.27% 84
2020
Q3
$3.82M Buy
43,898
+1,065
+2% +$92.3K 0.4% 66
2020
Q2
$3.74M Buy
42,833
+2,738
+7% +$236K 0.46% 65
2020
Q1
$3.31M Buy
40,095
+7,493
+23% +$669K 0.49% 61
2019
Q4
$3.09M Buy
32,602
+758
+2% +$68K 0.36% 75
2019
Q3
$2.77M Sell
31,844
-476
-1% -$42.7K 0.35% 78
2019
Q2
$2.95M Sell
32,320
-4,174
-11% -$353K 0.34% 82
2019
Q1
$3.14M Sell
36,494
-352
-1% -$28.3K 0.32% 88
2018
Q4
$2.83M Sell
36,846
-35,053
-49% -$2.73M 0.33% 89
2018
Q3
$5.55M Sell
71,899
-914
-1% -$67.6K 0.57% 61
2018
Q2
$4.93M Sell
72,813
-1,410
-2% -$97.3K 0.55% 61
2018
Q1
$5.38M Buy
74,223
+6,080
+9% +$463K 0.62% 58
2017
Q4
$5.13M Buy
68,143
+17,300
+34% +$1.31M 0.55% 61
2017
Q3
$3.91M Sell
50,843
-1,066
-2% -$80.5K 0.44% 69
2017
Q2
$3.88M Buy
51,909
+3,524
+7% +$250K 0.5% 69
2017
Q1
$3.22M Sell
48,385
-528
-1% -$35.2K 0.42% 80
2016
Q4
$3.19M Buy
48,913
+7,158
+17% +$464K 0.46% 73
2016
Q3
$2.95M Buy
41,755
+1,299
+3% +$94.7K 0.45% 74
2016
Q2
$2.99M Sell
40,456
-20,600
-34% -$1.42M 0.45% 77
2016
Q1
$3.96M Sell
61,056
-413
-0.7% -$28.1K 0.62% 57
2015
Q4
$4.74M Buy
61,469
+794
+1% +$63.1K 0.74% 47
2015
Q3
$5M Buy
60,675
+765
+1% +$68.1K 0.76% 49
2015
Q2
$5.28M Buy
59,910
+11,077
+23% +$1.02M 0.74% 51
2015
Q1
$4.32M Buy
48,833
+3,884
+9% +$345K 0.61% 54
2014
Q4
$3.73M Buy
44,949
+16,025
+55% +$1.33M 0.58% 56
2014
Q3
$2.44M Buy
28,924
+6,864
+31% +$555K 0.37% 82
2014
Q2
$1.79M Buy
22,060
+702
+3% +$55.2K 0.3% 97
2014
Q1
$1.63M Buy
21,358
+2,115
+11% +$154K 0.26% 105
2013
Q4
$1.39M Buy
19,243
+282
+1% +$19.6K 0.23% 111
2013
Q3
$1.3M Buy
18,961
+4,956
+35% +$328K 0.24% 111
2013
Q2
$887K Buy
+14,005
New +$911K 0.19% 116

Other funds holding NVS

SouthState Corp's NVS Position: Q2 2026 in Review

SouthState Corp reduced its Novartis (NVS) stake by 0.01% in Q2 2026, selling an estimated $150 and leaving 7,021 shares worth $1.1M. The position accounts for 0.05% of the portfolio, ranked #202.

SouthState Corp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.55M in Q3 2018. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • SouthState Corp held 7,021 shares of Novartis worth $1.1M as of Q2 2026.
  • SouthState Corp sold 1 Novartis share in Q2 2026, an estimated $150.
  • Novartis made up 0.05% of SouthState Corp's portfolio in Q2 2026, its #202 holding.
  • SouthState Corp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • SouthState Corp's Novartis position peaked at $5.55M in Q3 2018.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.